HER2 testing in gastric cancer: results of a German expert meeting
Valid HER2 testing is essential for optimal therapy of patients with HER2-positive gastric cancer and the correct use of first-line chemotherapy. While testing for HER2 status in breast cancer is routinely performed, this is not the case for HER2 testing in gastric cancer and it is usually only perf...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
11 March 2017
|
| In: |
Journal of cancer research and clinical oncology
Year: 2017, Jahrgang: 143, Heft: 5, Pages: 835-841 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-017-2374-x |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00432-017-2374-x Verlag, Volltext: https://doi.org/10.1007/s00432-017-2374-x 
|
| Verfasserangaben: | Florian Lordick, Salah-Eddin Al-Batran, Manfred Dietel, Timo Gaiser, Ralf-Dieter Hofheinz, Thomas Kirchner, Hans H. Kreipe, Sylvie Lorenzen, Markus Möhler, Alexander Quaas, Christoph Röcken, Josef Rüschoff, Andrea Tannapfel, Peter Thuss-Patience, Gustavo Baretton |